Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricVRTXVertex PharmaceuticalsGILDGilead SciencesREGNRegeneron Pharmaceuticals
Snapshot
Price$488.82$133.81$776.43
Market cap$115.02B$162.98B$68.59B
Valuation
P/E28.7x17.9x18.4x
Forward P/E27x12.8x17.6x
Growth
Revenue growth10.1%3.5%5.9%
EPS growth6.1%55.5%4.4%
Profitability
Net margin35.5%31.0%29.6%
ROE23.9%42.2%14.3%
Balance sheet & cash
Debt / equity0.01x1.1x0.09x
Free cash flow yield3.1%5.2%6.3%
Dividend yield—2.6%0.6%
Verdict
Investment ratingFavorable· 67Strong· 74Favorable· 69

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearVRTXtoday $489GILDtoday $134REGNtoday $776
2027$389.05 – $570.61+17% CAGR$156.05 – $228.87+71% CAGR$607.94 – $891.65+15% CAGR
2028$412.86 – $605.53+11% CAGR$242.64 – $355.87+63% CAGR$634.69 – $930.88+9% CAGR
2029$438.13 – $642.59+10% CAGR$377.27 – $553.34+61% CAGR$662.62 – $971.84+8% CAGR
2030$464.94 – $681.92+9% CAGR$586.62 – $860.38+59% CAGR$691.78 – $1,014.60+7% CAGR
2031$493.40 – $723.65+8% CAGR$912.14 – $1,337.81+58% CAGR$722.21 – $1,059.25+6% CAGR
5-yr CAGR0.2% – 8.2%46.8% – 58.5%-1.4% – 6.4%